Biostatistics primer: What a clinician ought to know: Hazard ratios

Journal of Thoracic Oncology

Volumn 6, Issue 6, 2011, Pages 978-982

  Barraclough, Helen ^a   Simms, Lorinda ^b   Govindan, Ramaswamy ^c,d  

^a ELI LILLY AUSTRALIA PTY LTD   (Australia)

^b ELI LILLY AND COMPANY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d USA   (United States)

Author keywords

Biostatistics; Hazard ratio; Proportional hazards; Survival analysis

Indexed keywords

ARTICLE; BIOSTATISTICS; HAZARD RATIO; MEDICAL DECISION MAKING; NEOPLASM; PRACTICE GUIDELINE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL;

BIOSTATISTICS; CLINICAL COMPETENCE; DATA INTERPRETATION, STATISTICAL; HUMANS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79958078253     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31821b10ab     Document Type: Article

References (7)

1. Altman DG, Bland JM. Time to event (survival) data. BMJ 1998;317: 468-469.
2. Cox DR. Regression models and life-tables. J R Stat Soc Series B Stat Methodol 1972;34:187-220.
3. Gould SJ. The median isn't the message. Discover 1985;6:40-42.
4. European Agency for the Evaluation of Medicinal Products (EMEA), Committee for Proprietary Medicinal Products (CPMP). Points to consider on adjustment for baseline covariates. CPMP/EWP/283/99, 2003.
5. Nieto FJ, Coresh J. Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol 1996;143:1059-1068. (Pubitemid 26140334)
6. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-241.
7. Barraclough H, Govindan R. Biostatistics primer: what a clinician ought to know: subgroup analyses. J Thorac Oncol 2010;5:741-746.